Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > May 2017

« Previous month Next month »

Chiltern acquires Japanese CRO

31-May-2017 - Chiltern has acquired Integrated Development Associates Co. Ltd. (IDA), a Japenese contract research organization (CRO) with offices in Japan, Korea, and Southeast Asia.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 - Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

31-May-2017 - This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others....

Pharma finance

The changing landscape of the CRO industry

30-May-2017 - How we classify CROs has seemingly changed overnight.

Mobile tech in clinical trials offers 'untapped potential,' says CEO

30-May-2017 - Patient-operated mobile technology will be demanded on all clinical trials, says mProve, as the industry undergoes an evolution and embraces digital health solutions.

CRO BioPharma Services completes 3 FDA inspections

30-May-2017 - The Canada-based contract research organization (CRO) has successfully completed three US FDA inspections this month.

ACRO: Right to Try Act compromises clinical trial process

25-May-2017 - Enhanced clinical trial design legislation proposes an alternative to the Right to Try Act – both of which address the FDA's current compassionate use program.

Hovione launches first clinical trial, more to come

25-May-2017 - Hovione has launched its first clinical trial and has already set sights on a second as the CDMO hopes to establish licensing partnership with pharma, says VP.

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.


Ashfield acquires contract sales organization, UDG raises FY guidance

24-May-2017 - Ashfield has acquired the German and Swiss contract sales outsourcing business Sellxpert for a reported $14.4m.

CDMO Recro expands manufacturing capabilities at former Alkermes site

24-May-2017 - Recro has added a new tablet manufacturing suite that enables it to compress single- and bi-layer tablets at commercial speeds.

CROS NT extends Medidata partnership

24-May-2017 - The extended partnership provides CROS NT customers access to Medidata’s electronic data capture (EDC) solution as well as its randomization and trial supply management system (RTSM).

PPD expands Virginia vaccine lab with an eye on assays

24-May-2017 - Pharmaceutical Product Development LLC (PPD) has expanded its vaccine research services lab in Richmond, Virginia.


Pace of change in clinical trial landscape has become rapid, says Avoca CEO

23-May-2017 - The Avoca Group is looking to take its collaboration model to the next level as it continues to address inefficiencies in clinical trial execution.

Evotec reaches pre-clinical milestone in Bayer alliance

23-May-2017 - Evotec AG has received a payment of approximately ‎€5m ($5.62m) as part of its strategic alliance with Bayer – which the company says is “well on track and very successful.”

SGS completes Ph I trial of new influenza virus

23-May-2017 - SGS has completed a Phase I clinical trial of a new influenza virus strain in healthy volunteers and has increased capacity at its Mississauga, Canada-based laboratory.

EMA proposal concerns: “Public health trumps commercial confidentiality”

23-May-2017 - Proposed amendments to the European Medicines Agency’s (EMA) access to documents policy have been criticised by medicines watchdogs, including not-for-profit Health Action International and Prescrire.

News in brief

CRO partners with humanized model developer to advance liver disease research

22-May-2017 - Seventh Wave Laboratories and Yecuris Corporation have announced an exclusive collaboration through which the CRO will provide various services.

Charles River partners with CRO to expand PDX model capabilities

22-May-2017 - Charles River Laboratories International, Inc. has partnered with OcellO to expand its PDX model capabilities and has made several additions to its online Tumor Model Compendium.

Report: CRO turnover creates loss of continuity

22-May-2017 - Contract research organizations (CROs) continue to see high instances of turnover, which can lead to delayed timelines and sponsor scrutiny, according to a recent survey.

Acurian: new consulting service provides 'continuum of support'

18-May-2017 - Acurian Inc. has launched a new consulting offering to help pharma sponsors throughout protocol design, enrollment, site planning, and budgeting.

PPD ups capacity at vaccine development lab

18-May-2017 - Pharmaceutical Product Development, LLC (PPD) has expanded its Richmond, Virginia-based vaccine sciences lab.

News in brief

Eli Lilly taps Cogstate as preferred provider

18-May-2017 - Eli Lilly and Company has chosen Cogstate as its preferred provider to support its Alzheimer’s disease platform.

LabCorp completes acquisition of PAML

17-May-2017 - LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.

CPhI North America

Cambrex invests $2.4m at former PharmaCore site

17-May-2017 - Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America....

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...